{
    "patient": {
        "Name": "Terry Simmons",
        "DateOfBirth": "1966-10-29",
        "Sex": "Male",
        "Diagnosis": "Chronic lymphocytic leukemia (CLL)",
        "BodyPart": "Leukemia",
        "Physician": "Dr. James Miller",
        "TreatingInstitution": "Austin Inc"
    },
    "specimen": {
        "Tumor specimen": {
            "source": "Leukemia",
            "CollectedDate": "2023-11-11",
            "ReceivedDate": "2023-11-18",
            "TumorPercentage": "1%"
        },
        "Normal specimen": {
            "source": "Blood",
            "CollectedDate": "2023-11-13",
            "ReceivedDate": "2023-11-14"
        }
    },
    "genomic variants": {
        "Somatic - Potentially Actionable": [
            {
                "Gene": "PKLR",
                "DNA Alteration": "c.1436G>A",
                "GeneMutation": "p.R479H Spliceregionvariant-GOF",
                "VariantAlleleFraction": "14.93%"
            },
            {
                "Gene": "XPC",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.S346P Nonsense-LOF",
                "VariantAlleleFraction": "29.57%"
            },
            {
                "Gene": "SDHB",
                "DNA Alteration": "c.487T>C",
                "GeneMutation": "p.S163P Frameshift-GOF",
                "VariantAlleleFraction": "27.84%"
            },
            {
                "Gene": "CD74",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.P98S Nonsense-LOF",
                "VariantAlleleFraction": "2.72%"
            }
        ],
        "Somatic - Biologically Relevant": [
            {
                "Gene": "PAX5",
                "DNA Alteration": "c.964G>A",
                "GeneMutation": "p.G183S Spliceregionvariant-LOF",
                "VariantAlleleFraction": "17.08%"
            }
        ],
        "Germline - Pathogenic": [],
        "Pertinent Negatives": []
    },
    "immunotherapy markers": [
        {
            "marker_name": "Tumor Mutational Burden",
            "TmbValue": "21 m/Mb",
            "Tmbpercentile": "48%",
            "Status type": "Microsatellite Instability Status",
            "statusvalue": "High"
        }
    ],
    "FDA-Approved Therapies": {
        "Current Diagnosis": [
            {
                "Mechanism": "KRAS G12C Inhibitors",
                "Medication": "Sotorasib",
                "Recommendations": [
                    "NCCN, Consensus, Non-Small Cell Lung Cancer",
                    "MSK OncoKB, Level 1"
                ],
                "Relevant Mutation": "KRASp.G12C G12C-GOF"
            }
        ],
        "Other Indications": [
            {
                "Mechanism": "KRAS G12C Inhibitors",
                "Medication": "Sotorasib",
                "Recommendations": [
                    "NCCN, Consensus, Non-Small Cell Lung Cancer",
                    "MSK OncoKB, Level 1"
                ],
                "Relevant Mutation": "KRASp.G12C G12C-GOF"
            }
        ]
    }
}